U.K. Stocks Rise as Anglo American, AstraZeneca Increase

U.K. stocks advanced to a six-week high as investors weighed quarterly results.

Anglo American Plc (AAL) added 3.1 percent after saying first-quarter iron-ore output jumped 10 percent. AstraZeneca Plc rose 2.8 percent after posting quarterly sales of cholesterol treatment Crestor and heartburn drug Nexium that exceeded analysts’ estimates. Unilever Plc lost 1.1 percent after saying revenue growth slowed from the fourth quarter.

The FTSE 100 Index (UKX) climbed 35.02 points, or 0.5 percent, to 6,709.76 at 9:28 a.m. in London. The benchmark gauge dropped yesterday as data showed new-house sales unexpectedly plunged in the U.S., while Chinese manufacturing contracted for a fourth month. The broader FTSE All-Share Index rose 0.5 percent today, while Ireland’s ISEQ Index increased 1 percent.

A Commerce Department report at 8:30 a.m. in Washington will show U.S. durable-goods orders advanced 2 percent in March, according to the median forecast of economists in a Bloomberg survey. They increased 2.2 percent in February. Separate data may show initial jobless claims rose to 315,000 in the week ended April 19.

To contact the reporter on this story: Inyoung Hwang in London at ihwang7@bloomberg.net

To contact the editors responsible for this story: Cecile Vannucci at cvannucci1@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.